128 related articles for article (PubMed ID: 15078250)
21. Variant Creutzfeldt-Jacob disease - the availability of a screening test will be the beginning, not the end, of difficult transfusion-related issues.
Sandler SG
Curr Opin Hematol; 2006 Nov; 13(6):445-6. PubMed ID: 17053456
[No Abstract] [Full Text] [Related]
22. Creutzfeldt-Jakob disease: blood infectivity and screening tests.
Brown P
Semin Hematol; 2001 Oct; 38(4 Suppl 9):2-6. PubMed ID: 11685719
[TBL] [Abstract][Full Text] [Related]
23. Creutzfeldt-Jakob disease.
Oney D
Pulse; 1999; 36(2):22. PubMed ID: 10614475
[No Abstract] [Full Text] [Related]
24. Removal of exogenous (spiked) and endogenous prion infectivity from red cells with a new prototype of leukoreduction filter.
Sowemimo-Coker S; Kascsak R; Kim A; Andrade F; Pesci S; Kascsak R; Meeker C; Carp R; Brown P
Transfusion; 2005 Dec; 45(12):1839-44. PubMed ID: 16371036
[TBL] [Abstract][Full Text] [Related]
25. Transfusion transmission of human prion diseases.
Zou S; Fang CT; Schonberger LB
Transfus Med Rev; 2008 Jan; 22(1):58-69. PubMed ID: 18063192
[TBL] [Abstract][Full Text] [Related]
26. Pall leukotrap affinity prion-reduction filter removes exogenous infectious prions and endogenous infectivity from red cell concentrates.
Sowemimo-Coker SO; Pesci S; Andrade F; Kim A; Kascsak RB; Kascsak RJ; Meeker C; Carp R
Vox Sang; 2006 May; 90(4):265-75. PubMed ID: 16635068
[TBL] [Abstract][Full Text] [Related]
27. Effect of protease treatment on plasma infectivity in variant Creutzfeldt-Jakob disease mice.
Yakovleva O; Janiak A; McKenzie C; McShane L; Brown P; Cervenakova L
Transfusion; 2004 Dec; 44(12):1700-5. PubMed ID: 15584983
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum. Tonsil biopsy helps diagnose new variant Creutzfeldt-Jakob disease.
Collinge J; Rossor MN; Thomas D; Frosh A; Tolley N
BMJ; 1998 Aug; 317(7156):472-3. PubMed ID: 9758471
[No Abstract] [Full Text] [Related]
29. Variant Creutzfeldt-Jakob disease and prions in the blood supply.
Rohwer RG; Drohan W
Clin Adv Hematol Oncol; 2004 Feb; 2(2):84, 87, 131. PubMed ID: 16163166
[No Abstract] [Full Text] [Related]
30. Methods to minimize the risks of Creutzfeldt-Jakob disease transmission by surgical procedures: where to set the standard?
Sutton JM; Dickinson J; Walker JT; Raven ND
Clin Infect Dis; 2006 Sep; 43(6):757-64. PubMed ID: 16912952
[TBL] [Abstract][Full Text] [Related]
31. An immunoassay for the pathological form of the prion protein based on denaturation and time resolved fluorometry.
Dabaghian RH; Barnard G; McConnell I; Clewley JP
J Virol Methods; 2006 Mar; 132(1-2):85-91. PubMed ID: 16219367
[TBL] [Abstract][Full Text] [Related]
32. Efficient detection of PrPSc (263K) in human plasma.
Fujita R; Urayama T; Ohmizu A; Yunoki M; Tsuji S; Ikuta K
Biologicals; 2006 Sep; 34(3):187-9. PubMed ID: 16257541
[TBL] [Abstract][Full Text] [Related]
33. Blood infectivity and the prospects for a diagnostic screening test in Creutzfeldt-Jakob disease.
Brown P; Cervenáková L; Diringer H
J Lab Clin Med; 2001 Jan; 137(1):5-13. PubMed ID: 11150018
[No Abstract] [Full Text] [Related]
34. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part I].
Zaborowski A
Psychiatr Pol; 2004; 38(2):283-96. PubMed ID: 15307293
[TBL] [Abstract][Full Text] [Related]
35. Presymptomatic detection of prions in blood.
Saá P; Castilla J; Soto C
Science; 2006 Jul; 313(5783):92-4. PubMed ID: 16825570
[TBL] [Abstract][Full Text] [Related]
36. Blood-transmitted prions and variant Creutzfeldt-Jakob disease.
Grady GF; Vyas GN
Biologicals; 2007 Apr; 35(2):75-7. PubMed ID: 17317213
[No Abstract] [Full Text] [Related]
37. [Aspects of the risks associated with vCJK from plasma derivatives from human plasma].
Burger R; Offergeld R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 Jun; 52(6):648-9. PubMed ID: 19557456
[No Abstract] [Full Text] [Related]
38. Current and future molecular diagnostics for prion diseases.
Lehto MT; Peery HE; Cashman NR
Expert Rev Mol Diagn; 2006 Jul; 6(4):597-611. PubMed ID: 16824033
[TBL] [Abstract][Full Text] [Related]
39. Prion safety of transfusion plasma and plasma-derivatives typically used for prophylactic treatment.
Svae TE; Neisser-Svae A; Bailey A; Reichl H; Biesert L; Schmidt T; Heger A; Römisch J
Transfus Apher Sci; 2008 Aug; 39(1):59-67. PubMed ID: 18619902
[TBL] [Abstract][Full Text] [Related]
40. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.
Krasnianski A; Meissner B; Schulz-Schaeffer W; Kallenberg K; Bartl M; Heinemann U; Varges D; Kretzschmar HA; Zerr I
Arch Neurol; 2006 Jun; 63(6):876-80. PubMed ID: 16769870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
